NCT06910930

Brief Summary

The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is:

  • Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed. Participants will:
  • Use DidgeriTU or sham device for 3 month
  • Do an online questionnaire once a month during the study
  • Home sleep test, lung function test, and tongue strength test at the start and end of the study

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

March 19, 2025

Last Update Submit

January 17, 2026

Conditions

Keywords

DeviceEMSTPowerbreathedidgeridoodidgeriTUExpiratory muscle exercisereverse CPAP

Outcome Measures

Primary Outcomes (1)

  • Change of apnea event after DidgeriTU usage compared with sham device

    Participants with a known history of non-severe obstructive sleep apnea will repeat the home sleep apnea test. The study will include patients with non-severe OSA(Apnea-hypopnea index 5-29/hr) from HSAT. After the usage of DidgeriTU or sham device for 3 months, the participant will repeat HSAT to explore the change of AHI after DidgeriTU use compared with sham device.

    3 months

Secondary Outcomes (7)

  • Change of OSA severity after the usage of DidgeriTU comparing with sham device

    3 months

  • Change in Epworth sleepiness scale after the usage of DidgeriTU comparing with sham device

    3 months

  • Change of maximum inspiratory pressure; MIP after DidgeriTU usage comparing with sham device

    3 months

  • Change of maximum expiratory mouth pressure; MEP after DidgeriTU usage comparing with sham device

    3 months

  • change in Pittsburg Sleep Quality Index; PSQI after DidgeriTU usage comparing with sham device

    3 months

  • +2 more secondary outcomes

Study Arms (2)

DidgeriTU

ACTIVE COMPARATOR

patients with non severe OSA using DidgeriTU device

Device: DidgeriTU

sham device

SHAM COMPARATOR

Patients with non severe OSA receive a device that look alike didgeriTU but without resistance plate

Device: Sham device

Interventions

DidgeriTUDEVICE

the study device that immitate the principle of didgeridoo for expiratory muscle exercise

DidgeriTU

a device that look alike DidgeriTU but without resistance plate

sham device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with mild to moderate obstructive sleep apnea.
  • Age 18 years or older.
  • Patients voluntarily consent to provide information for research purposes.

You may not qualify if:

  • Patients with an average apnea-hypopnea index (AHI) of \<4 or \>29 events per hour after repeated diagnosis using a home sleep apnea test.
  • Patients who refused to cease using CPAP during the study process
  • Patients with a history of chronic lung disease.
  • Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders.
  • Patients taking medications that may affect muscle function within 3 months before the start of the study.
  • Patients with hypothyroidism or other conditions that may affect muscle function.
  • Patients who consume alcohol at a moderate level or higher

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thammasat University Hospital

Pathum Thani, Thailand

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Naphitchaya Wiriya, Internal medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Naphitchaya Wiriya, MD.

Study Record Dates

First Submitted

March 19, 2025

First Posted

April 4, 2025

Study Start

May 1, 2025

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations